People · Operator

Tim Hoerr

Named in public records as an officer, director or promoter · active 2016–2020 · Medical Devices, Manufacturing

2
Companies
6
Filings
$14.1M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Nanomedical Diagnostics, Inc.Medical DevicesSeries A$12.0M$37.9M2016
Snooz, Inc.ManufacturingSeed$2.2M$16.6M2018
Operator network

Tim Hoerr at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Biao He · 5 companies · 1 sharedBiao HeNina Saberi · 5 companies · 1 sharedNina SaberiPaul Grint · 5 companies · 1 sharedPaul GrintJoseph Keegan · 4 companies · 1 sharedJoseph KeeganMichael Heltzen · 2 companies · 1 sharedMichael HeltzenRoss Bundy · 2 companies · 1 sharedRoss BundyBrett Goldsmith · 1 companies · 1 sharedBrett GoldsmithJonathan Kabakoff · 1 companies · 1 sharedJonathan KabakoffMatthew Snyder · 3 companies · 1 sharedMatthew SnyderEli Lazar · 1 companies · 1 sharedEli LazarEli S Lazar · 1 companies · 1 sharedEli S LazarMatthew MG Snyder · 1 companies · 1 sharedMatthew MG SnyderPatrick S McNally · 1 companies · 1 sharedPatrick S McNallyTim S Hoerr · 1 companies · 1 sharedTim S HoerrNanomedical Diagnostics, Inc. · $12.0M raisedNanomedical Diagnosti…Snooz, Inc. · $2.2M raisedSnooz, Inc.Tim HoerrTH
Tim Hoerr Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Tim Hoerr on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Paul Grint15
Nina Saberi15
Biao He15
Joseph Keegan14
Matthew Snyder13
Michael Heltzen12
Ross Bundy12
Eli Lazar11
Brett Goldsmith11
Jonathan Kabakoff11
Matthew MG Snyder11
Eli S Lazar11
Patrick S McNally11
Tim S Hoerr11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.